Please login to the form below

Not currently logged in


This page shows the latest Ultragenyx news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Jazz Pharma and Ultragenyx approvals, Autonomous AI in retinopathy

Daily Brief: Jazz Pharma and Ultragenyx approvals, Autonomous AI in retinopathy

Ultragenyx gains EU approval for rare disease drug Mepsevii. Ultragenyx has gained EU approval for Mepsevii in the EU, the first treatment approved in Europe for Mucopolysaccharidosis VII (MPS VII). ... MPS VII patients and families in Europe, people

Latest news

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2015 Deal Watch October 2015

    The research collaboration between Arcturus Therapeutics and Ultragenyx Pharmaceutical covers the discovery and development of mRNA therapeutics to certain rare disease targets using the Arcturus UNA Oligomer chemistry and LUNAR nanoparticle

  • Pharma deals during January 2013 Pharma deals during January 2013

    Deal Type. Comments. Baylor Research Institute. Ultragenyx. Collaboration. Triheptanoin UX 007 in rare and ultra-rare diseases. ... For example, Ultragenyx has in-licensed triheptanoin for long-chain fatty acid oxidation disorders from the Baylor

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Genentech’s Sunil Agarwal joins rare disease firm Genentech’s Sunil Agarwal joins rare disease firm

    He will serve as chief medical officer at Ultragenyx. Dr Sunil Agarwal has left his senior role at Genentech to join rare disease specialist Ultragenyx Pharmaceutical as its chief medical officer. ... In his new role at Ultragenyx Dr Agarwal will lead

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...